DURRANT, LINDA GILLIAN,BRENTVILLE, VICTORIA ANNE,METHERINGHAM, RACHEL LOUISE
申请号：
CA2985022
公开号：
CA2985022A1
申请日:
2016.07.19
申请国别(地区):
CA
年份:
2017
代理人:
摘要：
The present invention relates to modified citrullinated enolase peptides that can be used as targets for cancer immunotherapy. These peptides can be used as vaccines or as targets for monoclonal antibody (mAb) therapy. Such vaccines or mAbs may be used in the treatment of cancer.
